Procedure volumes for most of Johnson & Johnson’s device businesses returned to their pre-pandemic levels in the second quarter of 2021. However, a few markets, including orthopedic implants and vision surgery, are still showing some impact of COVID-19.
Worldwide operational sales for Johnson & Johnson’s medical device businesses grew 58.7% year over year, from just under $4.3bn in the second quarter of 2020 to almost $7bn in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?